ConductScience.org, home

Paper22876972

Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.

Chang CP and 5 others. Clin Sci (Lond), 2013. Cited by 218 papers, by iCite.

Cite this record

ConductScience Library. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Papers, record 22876972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22876972

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.
PubMed
Journal
Clin Sci (Lond)
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
218
iCite
Relative citation ratio, by iCite
7.78
iCite
Revised in PubMed
2022-04-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chang CPChing-Ping
2Chio CCChung-Ching
3Cheong CUChong-Un
4Chao CMChien-Ming
5Cheng BCBor-Chieh
6Lin MTMao-Tsun

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrainMajor topic
Brain InjuriesMajor topic
Culture Media, ConditionedMajor topic
Mesenchymal Stem CellsMajor topic
Animals
Apoptosis
Avoidance Learning
Bone Marrow Cells
Cell Hypoxia
Cells, Cultured
Enzyme-Linked Immunosorbent Assay
Hepatocyte Growth Factor
Humans
Male
Motor Activity
Neurogenesis
Neurons
Rats
Rats, Sprague-Dawley
Vascular Endothelial Growth Factor A

Source PubMed

Download CSV of topics

Cited by152

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 218 citations.

PMIDTitleJournalYearIn PapersSource
42645220Human Mesenchymal Stromal Cells Attenuate Hyperoxia-Induced Cellular Impairment of Immature Oligodendrocyte and Neurons.Cells2026https://conductscience.org/library/papers/42645220PubMed
42577309Effects of hypoxia on the biological characteristics of urine-derived stem cells.Front Cell Dev Biol2026https://conductscience.org/library/papers/42577309PubMed
41913036Quieting the Storm: Hypoxia as a Strategy to Boost UC-MSC Therapies for Hypoxic-Ischemic Brain Lesions in Neonatal Rats.Stem Cell Rev Rep2026https://conductscience.org/library/papers/41913036PubMed
41514404Effect of bone marrow stem cell conditioned medium on amiodarone-induced submandibular salivary gland and kidney damage in male albino rats.BMC Oral Health2026https://conductscience.org/library/papers/41514404PubMed
41210257Functional impacts of lactylation in Hypoxia‒primed mesenchymal stromal cells.Front Cell Dev Biol2025https://conductscience.org/library/papers/41210257PubMed
41096767Osteoporosis-Improving Effects of Extracellular Vesicles from Human Amniotic Membrane Stem Cells in Ovariectomized Rats.Int J Mol Sci2025https://conductscience.org/library/papers/41096767PubMed
40990865Hydrogen Sulfide-Preconditioned Mesenchymal Stem Cells Attenuate Ferroptosis in Corneal Alkali Burn via the AMPK/Nrf2/HO-1 Pathway in an IL-10-Dependent Manner.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/40990865PubMed
40933041Stem cell and CRISPR/Cas9 gene editing technology in Alzheimer's disease therapy: from basic research to clinical innovation.Front Genome Ed2025https://conductscience.org/library/papers/40933041PubMed
40589994Therapeutic role of mesenchymal stem cells in neurogenesis for management of neurological disorders: a scientometric study to an in-depth review.Front Neurol2025https://conductscience.org/library/papers/40589994PubMed
40352183Umbilical cord mesenchymal stem cell-derived secretome as a potential treatment for systemic lupus erythematosus: A double-blind randomized controlled trial.Narra J2025https://conductscience.org/library/papers/40352183PubMed
40158179Autoimmunity and clinical pathology amelioration in SLE by dexamethasone primed mesenchymal stem cell derived conditioned media.Stem Cell Res Ther2025https://conductscience.org/library/papers/40158179PubMed
39765683Unlocking the Therapeutic Potential of Adipose-Derived Stem Cell Secretome in Oral and Maxillofacial Medicine: A Composition-Based Perspective.Biology (Basel)2024https://conductscience.org/library/papers/39765683PubMed
39305405Therapeutic Applications of Engineered Mesenchymal Stromal Cells for Enhanced Angiogenesis in Cardiac and Cerebral Ischemia.Stem Cell Rev Rep2024https://conductscience.org/library/papers/39305405PubMed
39171894Biosponge-Encased Placental Stem Cells for Volumetric Muscle Loss Repair.Adv Wound Care (New Rochelle)2025https://conductscience.org/library/papers/39171894PubMed
39085403Neuroserpin normalization by mesenchymal stem cell therapy after encephalopathy of prematurity in neonatal rats.Pediatr Res2025https://conductscience.org/library/papers/39085403PubMed
38939990Neuro-regeneration or Repair: Cell Therapy of Neurological Disorders as A Way Forward.Curr Neuropharmacol2024https://conductscience.org/library/papers/38939990PubMed
38786067Preconditioning of MSCs for Acute Neurological Conditions: From Cellular to Functional Impact-A Systematic Review.Cells2024https://conductscience.org/library/papers/38786067PubMed
38615278Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease.Inflammopharmacology2024https://conductscience.org/library/papers/38615278PubMed
38523616Mapping knowledge of the stem cell in traumatic brain injury: a bibliometric and visualized analysis.Front Neurol2024https://conductscience.org/library/papers/38523616PubMed
38523514Potential Druggability of Mesenchymal Stem/Stromal Cell-derived Exosomes.Curr Stem Cell Res Ther2024https://conductscience.org/library/papers/38523514PubMed

See all 152 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22876972

GET https://conductscience.org/api/papers/v1/22876972/cited_by?page=2